Syntal Capital Partners, LLC Eli Lilly & CO Transaction History

Syntal Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $414,269 - $571,132	953 New	953 $511,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.39 Million - $1.59 Million	-4,693 Reduced 55.66%	3,738 $1.21 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.19 Million - $1.4 Million	4,285 Added 103.35%	8,431 $2.73 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $973,024 - $1.21 Million	4,146 New	4,146 $1.19 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.08 Million - $1.26 Million	-9,710 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $1.08 Million - $1.27 Million	9,710 New	9,710 $1.26 Million

4,229

755M

9.22M

10.9M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $802B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Syntal Capital Partners, LLC with notifications on news.